BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Retina
,
Avian flu virus
,
Trichostatin A
,
rs4950928
,
DRD2
,
T cell differentiation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CD248
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Colon cecum
Coronary artery
Pericardium
Vena cava
Parotid gland
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Sex-specific effects of CD248 on metabolism and the adipose tissue lipidome.
IgG78-DM1 inhibits pulmonary fibrosis by targeting and killing CD248-positive myofibroblasts in mice…
CD248 induces a maladaptive unfolded protein response in diabetic kidney disease.
Antibody-drug conjugates targeting CD248 inhibits liver fibrosis through specific killing on myofibr…
Antibody-drug conjugates targeting CD248+ myofibroblasts effectively alleviate renal fibrosis in mic…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of Serum Tumor Endothelial Marker1 as a Potential Biomarker for Colorectal Cancer Diagnos…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ